Clients
Engagement: ACO Execution and Strategy
National retail pharmacy and healthcare services organization
Engagement: MA MSO Development
VBC-focused PCP MSO operator in Florida
Engagement: PCP Platform Development
Physician Focused PE firm
Engagement: Corporate Dev Support
VBC-focused imagin solution, providing onsite radiology to PCP practices
Engagement: PCP M&A Pipeline Development
Healthcare and tech-enabled services focused PE firm
Select Clients & Engagements
At Accretive Health Advisors, we take pride in our trusted partnerships with medical practices and healthcare organizations. Our innovative solutions position our clients for enhanced revenue growth and financial security.
Explore some of our valued clients and the impactful engagements that fuel their success.
Engagement: FFS Payor Contracting
15-state dermatology & derm-path practice, sponsored by Harvest Capital Partners
Engagement: PCP M&A
Pipeline Development
Operates in 14 states, with strong overlap in several key Elevance Health markets
Engagement: FFS Payor Contracting
8-state cardiology practice, sponsored by Webster Capital Partners
Client Friendly Engagement Terms
Accretive provides low-risk, high-reward engagement terms
Monthly Retainer Fee
Cost Effective Fixed Fees based on size, scope and complexity of engagement. Partially offsets Accretive’s time and data costs required to analyze medical group market positioning, revenue opportunity and contract prioritization.
Performance Risk
Accretive believes in our ability to drive revenue performance and we take risk on our performance.Success Fees are tied to the incremental revenue Accretivegenerate for medical groups.
Flexible Term
If our initial review of medical group market positioning, contracts and transaction data determines there is immaterial revenue upside, Accretive will provide an early termination to the agreement.
Enterprise Value Creation
Accretive’s fees are generally treated as an EBITDA expense add back while preventing recurring P&L expenses related to staffing, systems and data. Contractual rate increases are generally treated as a pro forma addition to revenue and EBITDA.